Atlas Trials

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia

Clinical trial NCT00235352 · COMPLETED

Trial details

NCT number
NCT00235352
Sponsor
North Suffolk Mental Health Association
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2002-02-01
Primary completion
2005-04-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.